Medtech Insights

The US heart valve device market will continue to experience rapid growth, largely driven by the adoption of THV devices. Clinical investigations continue to generate positive results and propel…

The US market for interventional oncology devices will be driven by uptake of advanced and higher-priced technologies—such as radioembolization—favorable clinical data, expanding populations…

The European PV device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products such as drug-eluting technologies and IVL, as well as a…

Fueled by product innovation, rising kidney stone prevalence, and an aging population, the US market for urological devices will grow at a moderate rate through 2033, driven particularly by …

The Asia Pacific EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Asia Pacific countries, improved…

The European neurostimulation market will grow modestly through 2033. Growth in this market is largely driven by product innovations, particularly in the SCS and DBS segments, and iterative…

The Latin American sports medicine device market will expand through 2033, driven by continued growth in underpenetrated procedures, the introduction of innovative devices, and improved physician…

The US neurovascular device market will be fueled by increasing procedure volumes due to the rising number of CSCs in the country, greater adoption of thrombectomy for AIS management, and the…

The US IC device market is facing intense pricing pressure on established products, such as DES, limiting the overall market growth. However, steady uptake of novel, premium technologies has…

The MESA IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally invasive…

The US EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in US, improved access to treatment,…

The US neurostimulation device market will be driven by continuous product innovation, including product launches and device improvements targeting expanded indications. Strategic market…